Health Canada
- Status: approved
COS with GnRH antagonists and rFSH (COS with GnRH antagonists and rFSH) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Instituto Valenciano de Infertilidad, IVI VALENCIA is the originator. The local marketing authorisation holder may differ — check the official source linked above.